|
MRPL13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.628630E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.414300E-04 |
| Normal-vs-Stage2 |
1.080220E-01 |
| Normal-vs-Stage3 |
8.231100E-04 |
| Normal-vs-Stage4 |
3.39299999985165E-07 |
| Stage1-vs-Stage2 |
1.931630E-01 |
| Stage1-vs-Stage3 |
9.081600E-01 |
| Stage1-vs-Stage4 |
8.660500E-03 |
| Stage2-vs-Stage3 |
2.101800E-01 |
| Stage2-vs-Stage4 |
3.375500E-03 |
| Stage3-vs-Stage4 |
1.897970E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.609010E-04 |
| Normal-vs-AfricanAmerican |
8.902500E-03 |
| Normal-vs-Asian |
5.641600E-04 |
| Caucasian-vs-AfricanAmerican |
8.948200E-01 |
| Caucasian-vs-Asian |
8.667200E-01 |
| AfricanAmerican-vs-Asian |
8.006000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.26630000002659E-06 |
| Normal-vs-Female |
1.061430E-03 |
| Male-vs-Female |
4.048300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.175500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.846000E-04 |
| Normal-vs-Age(61-80Yrs) |
8.165200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.290800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.763800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.373600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.798200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.152830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.526580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.806000E-01 |
| Classical-VS-Follicular |
1.704850E-01 |
| Classical-VS-Other |
2.652600E-01 |
| Classical-VS-Normal |
2.25359999999064E-05 |
| Tall-VS-Follicular |
7.819400E-01 |
| Tall-VS-Other |
2.649000E-01 |
| Tall-VS-Normal |
1.608270E-02 |
| Follicular-VS-Other |
2.221400E-01 |
| Follicular-VS-Normal |
3.045700E-02 |
| Other-VS-Normal |
6.395400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.203960E-03 |
| Normal-vs-N1 |
1.09879999998785E-06 |
| N0-vs-N1 |
4.477100E-03 |
|
|
